Facioscapulohumeral Muscular Dystrophy Help fund a cure Ill do my part Will you do yours ??

Update posted by shawn welch On Nov 19, 2018

About the FSH Society Founded in 1991 by patients, the FSH Society is the world’s pre-eminent research- focused patient advocacy organization for facioscapulohumeral muscular dystrophy (FSHD) patients, their families, and research activists.

What Is FSHD? Facioscapulohumeral muscular dystrophy, or FSHD, is a genetic disorder that causes weakening of the skeletal muscles. Typically beginning in early adolescence with the loss of muscle strength in the face (facio), shoulders (scapula), upper arms (humer- us), legs or core, FSHD can spread to any muscle. Ten to 30 percent of patients have onset of symptoms before age 10. About 20 percent will need a wheelchair by age 50. Over 70 percent experience debilitating pain and fatigue. There is no effective treatment or cure—but there is hope.

photo

An experimental gene therapy has been shown to enlarge and strengthen muscles in a mouse model of facioscapulohumeral muscular dystrophy (FSHD). The study was published on November 15 in the Journal of Clinical Investigation Insight by Scott Harper, PhD, and his team at Nationwide Children’s Hospital.

shawn welch

Update posted by Nov 20

photo

Facio Therapies announced today that oral treatment with one of Facio’s lead candidates results in significant reduction of the human muscle-toxic DUX4 protein in mice engrafted with human FSHD-affected muscle cells. Facio is the first in the FSHD field to achieve proof of principle in an animal model (“in vivo”)

shawn welch

Update posted by Nov 19

Add a Comment

photo

Jeff Silverman

Backed with $25.00 On Dec 09, 2018

Add a Comment

photo

shawn welch

Campaign Owner

send a message

photo

Peter Pogozelski

Manager

send a message

No Followers Just Yet...

Create Support Campaign

Not Ready to Donate?

Did you know a 10 second Facebook share raises an average of $25?

Share on